PRONTOSAN
Device
B. Braun Medical Inc.
Total Payments
$45,400
Transactions
5
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $45,400 | 5 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $33,000 | 2 | 72.7% |
| Consulting Fee | $12,400 | 3 | 27.3% |
Payments by Type
Research
$33,000
2 transactions
General
$12,400
3 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| GEL TREATMENT OF 2ND DEGREE FACIAL BURNS | B. Braun Medical Inc. | $30,000 | 0 |
| SAFETY OF 1 G AND 2 G OF CEFAZOLIN IN PEDIATRIC SUBJECTS | B. Braun Medical Inc. | $3,000 | 0 |
Ad
Manufacturing Companies
- B. Braun Medical Inc. $45,400
Product Information
- Type Device
- Total Payments $45,400
- Total Doctors 3
- Transactions 5
About PRONTOSAN
PRONTOSAN is a device associated with $45,400 in payments to 3 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is B. Braun Medical Inc..
Payment data is available from 2021 to 2021. In 2021, $45,400 was paid across 5 transactions to 3 doctors.
The most common payment nature for PRONTOSAN is "Unspecified" ($33,000, 72.7% of total).
PRONTOSAN is associated with 2 research studies, including "GEL TREATMENT OF 2ND DEGREE FACIAL BURNS" ($30,000).